Alak AM and Lizak PP |
Quality assurance procedure for monitoring tacrolimus (FK506) concentrations in whole blood by IMx assay. |
1996 |
Ther Drug Monit |
pmid:8738766
|
Ockenfels HM et al. |
Inhibition of T cell cAMP formation by cyclosporin A and FK506. |
1996 |
Naunyn Schmiedebergs Arch. Pharmacol. |
pmid:8740144
|
Thompson PA and Mosley CA |
Tacrolimus-phenytoin interaction. |
1996 |
Ann Pharmacother |
pmid:8740340
|
Cooley HM et al. |
Resolution of pyoderma gangrenosum using tacolimus (FK-506) |
1996 |
Aust N Z J Med |
pmid:8744629
|
Nowaczyk M et al. |
2-Chlorodeoxyadenosine: lack of synergism with cyclosporine A and tacrolimus (FK 506). |
1995 |
Arch. Immunol. Ther. Exp. (Warsz.) |
pmid:8744655
|
Sheppard KE |
Cyclosporin A and FK506 are potent activators of proopiomelanocortin-derived peptide secretion without affecting corticotrope glucocorticoid receptor function. |
1995 |
J. Neuroendocrinol. |
pmid:8748119
|
Jonas S et al. |
Conversion to tacrolimus after liver transplantation. |
1996 |
Transpl. Int. |
pmid:8748407
|
Miranker A and Karplus M |
An automated method for dynamic ligand design. |
1995 |
Proteins |
pmid:8749844
|
Seifeldin R |
Drug interactions in transplantation. |
1995 Nov-Dec |
Clin Ther |
pmid:8750397
|
Ichinari H et al. |
Effects of portal venous inoculation with donor splenocytes on lung allograft survival in dogs. |
1996 |
J. Thorac. Cardiovasc. Surg. |
pmid:8751494
|
Sunyecz JA et al. |
Lymphoproliferative disorder involving the cervix in a patient being treated with FK-506. |
1996 |
Gynecol. Oncol. |
pmid:8751565
|
Ho SN et al. |
Dimeric ligands define a role for transcriptional activation domains in reinitiation. |
1996 |
Nature |
pmid:8752278
|
Motamedi H et al. |
Characterization of methyltransferase and hydroxylase genes involved in the biosynthesis of the immunosuppressants FK506 and FK520. |
1996 |
J. Bacteriol. |
pmid:8752344
|
Yamashita M et al. |
Non-T cell-derived IL-4 plays an important role in IgE production induced by antigen resensitization and is resistant to FK506. |
1996 |
J. Immunol. |
pmid:8752921
|
Sperr WR et al. |
Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cells. |
1996 |
J. Allergy Clin. Immunol. |
pmid:8757216
|
Venkataraman L et al. |
Differential regulation of c-Rel translocation in activated B and T cells. |
1996 |
J. Immunol. |
pmid:8757620
|
Brunner T et al. |
Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506. |
1996 |
Int. Immunol. |
pmid:8757947
|
Gusev AI et al. |
A quantitative study of in vitro hepatic metabolism of tacrolimus (FK506) using secondary ion and matrix-assisted laser desorption/ionization mass spectrometry. |
1996 |
Rapid Commun. Mass Spectrom. |
pmid:8759330
|
Rokaw MD et al. |
FK-506 and rapamycin but not cyclosporin inhibit aldosterone-stimulated sodium transport in A6 cells. |
1996 |
Am. J. Physiol. |
pmid:8760046
|
Tomono M et al. |
Calcineurin is essential for DNA synthesis in Swiss 3T3 fibroblasts. |
1996 |
Biochem. J. |
pmid:8760349
|
Becker G et al. |
Diltiazem minimizes tubular damage due to FK506-mediated nephrotoxicity following ischemia and reperfusion in rats. |
1996 |
Transpl. Immunol. |
pmid:8762016
|
Masaki Y et al. |
Microchimerism and rat small bowel transplantation combined with donor-type bone marrow cells. |
1996 |
Transplant. Proc. |
pmid:8769154
|
Jordan ML et al. |
Tacrolimus rescue therapy for renal transplant rejection. |
1996 |
Transplant. Proc. |
pmid:8769174
|
Baruch Y et al. |
Anasarca and hypertrophic cardiomyopathy in a liver transplant patient on FK506: relieved after a switch to Neoral. |
1996 |
Transplant. Proc. |
pmid:8769215
|
Melter M et al. |
Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients. |
1996 |
Transplant. Proc. |
pmid:8769224
|
Tanaka M et al. |
Reduction of immunosuppressive agents after living related donor liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8769268
|
Randhawa PS et al. |
Microvascular changes in renal allografts associated with FK506 (Tacrolimus) therapy. |
1996 |
Am. J. Surg. Pathol. |
pmid:8772784
|
Ichikawa Y et al. |
Three-times-daily monotherapy with tacrolimus (FK 506) in kidney transplantation. |
1996 |
Int. J. Urol. |
pmid:8776613
|
Mugiya S et al. |
Renal blood flow and serotonin metabolism in tacrolimus treated rats. |
1996 |
Int. J. Urol. |
pmid:8776615
|
Dmitrewski J et al. |
Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression. |
1996 |
J. Hepatol. |
pmid:8778189
|
Schwarz A |
[Drug-induced kidney damage]. |
1996 |
Z Arztl Fortbild (Jena) |
pmid:8779233
|
Newell KA et al. |
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression. |
1996 |
Transplantation |
pmid:8779685
|
Lufft V et al. |
Incidence of Pneumocystis carinii pneumonia after renal transplantation. Impact of immunosuppression. |
1996 |
Transplantation |
pmid:8779695
|
Craescu CT et al. |
Three-dimensional structure of the immunophilin-like domain of FKBP59 in solution. |
1996 |
Biochemistry |
pmid:8780506
|
Singh N and Yu VL |
Prophylaxis for cytomegalovirus disease after liver transplant. |
1996 |
Clin. Infect. Dis. |
pmid:8783744
|
Steiner JP et al. |
Immunophilin regulation of neurotransmitter release. |
1996 |
Mol. Med. |
pmid:8784785
|
Silva ND and Prendergast FG |
Tryptophan dynamics of the FK506 binding protein: time-resolved fluorescence and simulations. |
1996 |
Biophys. J. |
pmid:8785272
|
Wagenknecht T et al. |
Cryoelectron microscopy resolves FK506-binding protein sites on the skeletal muscle ryanodine receptor. |
1996 |
Biophys. J. |
pmid:8785329
|
Dumont FJ et al. |
Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization. |
1996 |
J. Pharmacol. Exp. Ther. |
pmid:8786538
|
Michel G et al. |
Antioncogene P53 and mitogenic cytokine interleukin-8 aberrantly expressed in psoriatic skin are inversely regulated by the antipsoriatic drug tacrolimus (FK506). |
1996 |
Biochem. Pharmacol. |
pmid:8787547
|
Gonschior AK et al. |
Tacrolimus (FK506) metabolite patterns in blood from liver and kidney transplant patients. |
1996 |
Clin. Chem. |
pmid:8787699
|
Venkataramanan R et al. |
Clinical pharmacokinetics of tacrolimus. |
1995 |
Clin Pharmacokinet |
pmid:8787947
|
Ikebe S et al. |
Immunosuppressive effect of tacrolimus (FK-506). Bone xenografts in rabbits. |
1996 |
Acta Orthop Scand |
pmid:8792745
|
Abu-Elmagd K et al. |
The current status of hepatic transplantation at the University of Pittsburgh. |
1995 |
Clin Transpl |
pmid:8794262
|
Shapiro R et al. |
The superiority of tacrolimus in renal transplant recipients -- the Pittsburgh experience. |
1995 |
Clin Transpl |
pmid:8794266
|
Buckle GJ et al. |
HTLV-I-induced T-cell activation. |
1996 |
J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. |
pmid:8797712
|
Platz KP et al. |
Management of acute steroid-resistant rejection after liver transplantation. |
1996 |
World J Surg |
pmid:8798364
|
Brunke M et al. |
Luciferase assembly after transport into mammalian microsomes involves molecular chaperones and peptidyl-prolyl cis/trans-isomerases. |
1996 |
J. Biol. Chem. |
pmid:8798557
|
Zhang Q et al. |
Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. |
1996 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:8799169
|
Spencer DM et al. |
Functional analysis of Fas signaling in vivo using synthetic inducers of dimerization. |
1996 |
Curr. Biol. |
pmid:8805308
|
Franke EK and Luban J |
Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. |
1996 |
Virology |
pmid:8806510
|
Ho S et al. |
The mechanism of action of cyclosporin A and FK506. |
1996 |
Clin. Immunol. Immunopathol. |
pmid:8811062
|
Nishino H et al. |
3-Nitropropionic acid produces striatum selective lesions accompanied by iNOS expression. |
1996 |
J. Chem. Neuroanat. |
pmid:8811425
|
Sonatore LM et al. |
The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains. |
1996 |
Anal. Biochem. |
pmid:8811923
|
Paus R et al. |
Hair growth control by immunosuppression. |
1996 |
Arch. Dermatol. Res. |
pmid:8818191
|
Michel G et al. |
FK506 in the treatment of inflammatory skin disease: promises and perspectives. |
1996 |
Immunol. Today |
pmid:8820265
|
Boeve BF et al. |
Dysarthria and apraxia of speech associated with FK-506 (tacrolimus). |
1996 |
Mayo Clin. Proc. |
pmid:8820772
|
Komatsu K et al. |
Prolonged survival of hamster-to-rat pulmonary xenografts by tacrolimus (FK506) and cyclophosphamide. |
1996 |
J. Heart Lung Transplant. |
pmid:8820789
|
Hodgkiss JP and Kelly JS |
Only 'de novo' long-term depression (LTD) in the rat hippocampus in vitro is blocked by the same low concentration of FK506 that blocks LTD in the visual cortex. |
1995 |
Brain Res. |
pmid:8821755
|
Hayashi K et al. |
Suppression of experimental crescentic-type anti-glomerular basement membrane (GBM) nephritis by FK506 (tacrolimus hydrate) in rats. |
1996 |
Jpn. J. Pharmacol. |
pmid:8822088
|
Sasahara Y et al. |
Okadaic acid suppresses neural differentiation-dependent expression of the neurofilament-L gene in P19 embryonal carcinoma cells by post-transcriptional modification. |
1996 |
J. Biol. Chem. |
pmid:8824230
|
Lang T et al. |
Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. |
1996 |
Transplantation |
pmid:8824477
|
Matsuda H et al. |
Interactions of FK506 (tacrolimus) with clinically important drugs. |
1996 |
Res. Commun. Mol. Pathol. Pharmacol. |
pmid:8824931
|
Woodle ES et al. |
Treatment of acute glomerular rejection with FK 506. |
1996 |
Clin Transplant |
pmid:8826664
|
Seifeldin R et al. |
Effect of nifedipine on renal function in liver transplant recipients receiving tacrolimus. |
1996 May-Jun |
Clin Ther |
pmid:8829025
|
Moriwaki A et al. |
Immunosuppressant FK506 prevents mossy fiber sprouting induced by kindling stimulation. |
1996 |
Neurosci. Res. |
pmid:8829156
|
Ankarcrona M et al. |
Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. |
1996 |
FEBS Lett. |
pmid:8830666
|
Alessiani M et al. |
Combined immunosuppressive therapy with tacrolimus and mycophenolate mofetil for small bowel transplantation in pigs. |
1996 |
Transplantation |
pmid:8830816
|
Woodle ES et al. |
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. |
1996 |
Transplantation |
pmid:8830821
|
Tanaka M et al. |
Effect of anticomplement agent K76 COOH on hamster-to-rat and guinea pig-to-rat heart xenotransplantation. |
1996 |
Transplantation |
pmid:8830837
|
Opelz G |
Comparison of FK506 and cyclosporine. |
1996 |
Transplantation |
pmid:8830844
|
Mysliwiec J et al. |
The effect of tacrolimus (FK506) and cyclosporin A (CyA) on peripheral serotonergic mechanisms in uremic rats. |
1996 |
Thromb. Res. |
pmid:8837316
|
Lamb GD and Stephenson DG |
Effects of FK506 and rapamycin on excitation-contraction coupling in skeletal muscle fibres of the rat. |
1996 |
J. Physiol. (Lond.) |
pmid:8842013
|
Tanaka K et al. |
Effect of cyclosporin analogues and FK506 on transcellular transport of daunorubicin and vinblastine via P-glycoprotein. |
1996 |
Pharm. Res. |
pmid:8842048
|
Borvak J et al. |
The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus. |
1996 |
J. Infect. Dis. |
pmid:8843228
|
Borg AJ et al. |
15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes. |
1996 |
Transpl. Immunol. |
pmid:8843590
|
Chen BG et al. |
Inhibition by CsA and FK506 of the in vitro proliferative response of gamma delta T cells on stimulation with anti-TCR delta monoclonal antibody. |
1996 |
Transpl. Immunol. |
pmid:8843593
|
Toyota N et al. |
Effects of FK506 and cyclosporin A on proliferation, histamine release and phenotype of murine mast cells. |
1996 |
Arch. Dermatol. Res. |
pmid:8844128
|
Stempfle HU |
[Osteoporosis following heart transplantation. Pathogenesis and therapy]. |
1996 |
Dtsch. Med. Wochenschr. |
pmid:8846757
|
Akashi T et al. |
Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography. |
1996 |
J Pharm Biomed Anal |
pmid:8851758
|
Wada Y et al. |
BCX-34: a novel T-cell selective immunosuppressant: purine nucleoside phosphorylase (PNP) inhibitor. |
1996 |
Artif Organs |
pmid:8853794
|
Lochmüller H et al. |
Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. |
1996 |
Gene Ther. |
pmid:8854096
|
Horn F and Gross J |
A role for calcineurin in Dictyostelium discoideum development. |
1996 |
Differentiation |
pmid:8855370
|
Holt DW et al. |
Quality assessment issues of new immunosuppressive drugs and experimental experience. |
1996 |
Ther Drug Monit |
pmid:8857551
|
McMichael J et al. |
Computer-guided randomized concentration-controlled trials of tacrolimus in autoimmunity: multiple sclerosis and primary biliary cirrhosis. |
1996 |
Ther Drug Monit |
pmid:8857564
|
Bartlett ST et al. |
Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. |
1996 |
Ann. Surg. |
pmid:8857849
|
Takuma T et al. |
Dephosphorylation of cofilin in parotid acinar cells. |
1996 |
J. Biochem. |
pmid:8864841
|
Yamada A et al. |
Long-term acceptance of major histocompatibility complex-mismatched cardiac allograft induced by a low dose of CTLA4IgM plus FK506. |
1996 |
Microbiol. Immunol. |
pmid:8865157
|
Christians U et al. |
Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes. |
1996 |
Br J Clin Pharmacol |
pmid:8866917
|
Dawson TM |
Immunosuppressants, immunophilins, and the nervous system. |
1996 |
Ann. Neurol. |
pmid:8871573
|
Small SL et al. |
Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506) |
1996 |
Ann. Neurol. |
pmid:8871576
|
Sadakane Y and Nakashima H |
Light-induced phase shifting of the circadian conidiation rhythm is inhibited by calmodulin antagonists in Neurospora crassa. |
1996 |
J. Biol. Rhythms |
pmid:8872595
|
Jordan ML et al. |
The use of tacrolimus in renal transplantation. |
1996 |
World J Urol |
pmid:8873438
|
Clark W |
Tacrolimus: immunosuppression following liver and kidney transplant. |
1996 |
J Clin Pharm Ther |
pmid:8873845
|
DiMartini AF et al. |
Prospective study of FK506 side effects: anxiety or akathisia? |
1996 |
Biol. Psychiatry |
pmid:8874843
|
Lu YF et al. |
Calcineurin inhibitors, FK506 and cyclosporin A, suppress the NMDA receptor-mediated potentials and LTP, but not depotentiation in the rat hippocampus. |
1996 |
Brain Res. |
pmid:8874888
|
Barkholt LM et al. |
Epstein-Barr virus DNA in serum after liver transplantation--surveillance of viral activity during treatment with different immunosuppressive agents. |
1996 |
Transpl. Int. |
pmid:8875785
|
Morris-Stiff G et al. |
Haemolytic uraemic syndrome associated with OKT3. |
1996 |
Transpl. Int. |
pmid:8875800
|
Kitagawa H et al. |
Cloning and high expression of rabbit FKBP25 in cornea. |
1996 |
Jpn. J. Ophthalmol. |
pmid:8876379
|
Laskow DA et al. |
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. |
1996 |
Transplantation |
pmid:8878381
|